These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2888668)

  • 21. Effects of alpha 1- and alpha 2-adrenoceptor antagonists on venous tone in conscious rats.
    D'Oyley HM; Pang CC
    Eur J Pharmacol; 1990 Jul; 182(2):283-90. PubMed ID: 1975781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corynanthine inhibits, while idazoxan potentiates, cardiotoxic effects of ouabain.
    Thomas GP
    J Auton Pharmacol; 1995 Apr; 15(2):85-91. PubMed ID: 7615577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for a peripheral component in the sympatholytic effect of clonidine in rats.
    Brown MJ; Harland D
    Br J Pharmacol; 1984 Nov; 83(3):657-65. PubMed ID: 6150737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
    Doxey JC; Roach AG; Strachan DA; Virdee NK
    Br J Pharmacol; 1984 Nov; 83(3):713-22. PubMed ID: 6150740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of alpha-adrenoceptor antagonists on the mydriatic and bradycardic effects of detomidine.
    Hanson CE; Hsu WH
    Arch Int Pharmacodyn Ther; 1987 Jun; 287(2):291-8. PubMed ID: 2888443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation by central postsynaptic alpha 2-adrenoceptors of the jaw-opening reflex induced by orofacial stimulation in rats.
    García-Vallejo P; Barturen F; García-Sevilla JA
    Br J Pharmacol; 1994 Apr; 111(4):1140-6. PubMed ID: 8032600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-Alkyl analogue of idazoxan (RX 781094) with enhanced antagonist potency and selectivity at central alpha 2-adrenoceptors in the rat.
    Gadie B; Lane AC; McCarthy PS; Tulloch IF; Walter DS
    Br J Pharmacol; 1984 Nov; 83(3):707-12. PubMed ID: 6150739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
    Wright IK; Blaylock NA; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Feb; 114(3):678-88. PubMed ID: 7735695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective alpha 2-adrenoceptor blockade does not enhance glucose-evoked insulin release.
    John GW; Doxey JC; Walter DS; Reid JL
    Eur J Pharmacol; 1990 Oct; 187(3):531-6. PubMed ID: 1981556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of some alpha-adrenoceptor antagonists on spontaneous myogenic activity in the rat portal vein and the putative involvement of ATP-sensitive K+ channels.
    Schwietert R; Wilhelm D; Wilffert B; Van Zwieten PA
    Eur J Pharmacol; 1992 Jan; 211(1):87-95. PubMed ID: 1352250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.
    Pinthong D; Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Jun; 115(4):689-95. PubMed ID: 7582492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha 2-adrenoceptor-blocking properties of midaglizole (DG-5128) in rats.
    Hirohashi M; Tanaka M; Suzuki I; Akashi A
    Arch Int Pharmacodyn Ther; 1990; 306():75-86. PubMed ID: 1981668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. alpha-Methyldopa produces mydriasis in the rat by stimulation of CNS alpha 2-adrenoceptors.
    Hey JA; Ito T; Koss MC
    Br J Pharmacol; 1988 Jul; 94(3):834-8. PubMed ID: 2902894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pharmacokinetic-pharmacodynamic linking model for the alpha 2-adrenergic antagonism of idazoxan on clonidine-induced mydriasis in the rat.
    Valles J; Obach R; Menargues A; Pruñonosa J; Jane F
    J Pharm Pharmacol; 1995 Feb; 47(2):157-61. PubMed ID: 7602472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmitter release modulated by alpha-adrenoceptor antagonists in the rabbit mesenteric artery: a comparison between noradrenaline outflow and electrical activity.
    Mishima S; Miyahara H; Suzuki H
    Br J Pharmacol; 1984 Oct; 83(2):537-47. PubMed ID: 6148987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part II: Central and peripheral nervous systems.
    Hirohashi M; Takasuna K; Kasai Y; Usui C; Kojima H
    Arzneimittelforschung; 1991 Jan; 41(1):19-24. PubMed ID: 1675569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Responses to norepinephrine resistant to inhibition by alpha and beta adrenoceptor antagonists.
    Bond RA; Charlton KG; Clarke DE
    J Pharmacol Exp Ther; 1986 Feb; 236(2):408-15. PubMed ID: 2868118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Idazoxan (RX 781094) selectively antagonizes alpha 2-adrenoceptors on rat central neurons.
    Freedman JE; Aghajanian GK
    Eur J Pharmacol; 1984 Oct; 105(3-4):265-72. PubMed ID: 6150858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of alpha-2 adrenergic receptor subtypes in hyperglycemia.
    Angel I; Niddam R; Langer SZ
    J Pharmacol Exp Ther; 1990 Sep; 254(3):877-82. PubMed ID: 1975624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.